Gynecologic and breast cancers with hereditary cancer predisposition syndromes
Approximately 20–25% of ovarian cancers, 5–10% of uterine cancers, and 5–10% of breast cancers are attributable to inherited pathogenic genetic alterations. Identifying characteristic germline mutations is crucial for patient management, as appropriate surveillance and further surgical interventions...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-11-01
|
Series: | Human Pathology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772736X24000367 |